Aphria Receives Licence Amendment to Sell Oil Extracts

LEAMINGTON, ONTARIO–(Marketwired – Aug. 17, 2016) – Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company received an amendment to its licence to produce and sell medical cannabis from Health Canada under the Marihuana for Medical Purposes Regulations. The licence amendment provides for the production and sale of cannabis oil extracts.

The Company originally received an amendment to its licence to produce cannabis oil in August 2015. In the interim, the Company has…

ORIGINAL SOURCE: Click Here to Continue Reading Article…